BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
22 hedge funds and large institutions have $1.08M invested in Baudax Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Walleye Capital
New York
|
$165K |
| 2 |
2
Renaissance Technologies
New York
|
$271K |
| 3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$40K |
| 4 |
HF
4
HRT Financial
New York
|
$19K |
| 5 |
VF
5
Virtu Financial
New York
|
$17K |
Top Sellers
| 1 |
1
D.E. Shaw & Co
New York
|
$0 |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$50K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$0 |
| 4 |
4
Jane Street
New York
|
$0 |
| 5 |
5
BlackRock
New York
|
$27K |
